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REPORT
The adherence to UK legislation by online shops selling
new psychoactive substances
Elle Wadsworth, Colin Drummond, and Paolo Deluca
National Addiction Centre, King’s College London, London, UK
Abstract
Aims: On the 26th of May 2016, the UK Government introduced the Psychoactive Substances
Act, 2016. The aim of this short report is to explore online shops selling New Psychoactive
Substances (NPS) stated motivations for closing and the changes that arose preceding the ban.
Methods: The search for online shops selling NPS was made throughout October 2015. From
March to June 2016, data were collected on the status of the online shops, and whether they
mentioned the ban, the delay, or their closure. Results: From the original 113 online shops, only
52% remained open. Those that remained were either based overseas (65%), removed NPS and
became a headshop (19%), or were inactive (16%). Only 24% of UK-registered websites
remained open after the ban. Conclusions: UK-registered websites closed down or moved
domain locations and no longer sold to UK customers. UK-registered websites communicated
with customers at each stage of the legislation. It is unknown whether the UK retailers have
ceased selling NPS or have been displaced to underground markets (street level dealing or the
hidden web). The majority of shops in this study were located in Europe or North America,
showing that there is still high demand in both continents.
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Introduction
Online suppliers of New Psychoactive Substances (NPS) on
the surface web (the web that can be accessed by general
search engines such as Google or Bing) have revolutio-
nised the drugs marketplace and it reflects the modern,
demand-based approach of e-commerce (Seddon, 2014).
Customers can purchase drugs from online shops from
anywhere in the world from their home, work or mobile
phone. The benefit to purchasing online compared to
traditional street level dealing, is that the consumer can
access harm reduction advice and reviews on products and
both the consumer and the supplier feel more secure due to
lack of physical contact, (EMCDDA & Europol, 2016;
Seddon, 2014). Online supply is a growing platform, mirror-
ing the global increasing use of the Internet (EMCDDA &
Europol, 2016).
Evidence is mixed to what the predominant method of
obtaining NPS is. Some suggest the majority of NPS are
bought online (Fattore & Fratta, 2011), whereas others find
that it was predominantly through friends or street level drug
dealers (European Commission, 2014). In 2013, there were
651 online shops selling NPS, listing in pounds or euros and
shipping to Europe (EMCDDA, 2014). The UK is a popular
market for NPS with an estimate of around a fifth of the
online shops in 2011 based there, the second largest source
after the USA (Schmidt, Sharma, Schifano, & Feinmann,
2011). The products available on the surface web vary with
availability and with legislation (Smith & Garlich, 2013).
Suppliers remove substances that are controlled or continue
selling the controlled substances but under different descrip-
tions (Home Office, 2014a). However, the UK’s Home Office
found that when chemical names of active ingredients are
stated on NPS packets sold online, they do reflect the contents
of products (Home Office, 2014b).
It is suggested that non-controlled NPS are sold on the
surface web and in offline retail vendors, such as ‘‘head-
shops’’ that specialise in drug paraphernalia, and controlled
substances are sold on the hidden web (an online network that
cannot be accessed via regular search engines), or non-retail
vendors such as street dealers (Home Office, 2014a). Schmidt
et al. (2011) found that there is an increasing number of grey
marketplace developments, where some surface web websites
have sales taking place on the hidden web, once sellers have
‘‘built trust’’ with sellers, or to sell controlled NPS.
Following similar footsteps of Ireland and Poland (Hughes
& Winstock, 2012), the UK Government introduced the
Psychoactive Substances Act, 2016 on the 26th May of 2016
(UK Government, 2016). The Act was originally set to come
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into force in April 2016 but was delayed due to concerns that
the broad definition of a psychoactive substance would
complicate enforcement. The Act controls all psychoactive
substances (with some exemptions), that are not already
controlled by the Misuse of Drugs Act (UK Government,
2016). In the Psychoactive Substances Act, possession is not
an offence, but supply and production is criminalised, and its
intention therefore was to close all online and offline retail
sales.
The Psychoactive Substances Act has received criticism
and it has been argued that prohibition will simply
displace the market from visible Internet sales and offline
shops to criminal networks (Reuter & Pardo, 2016;
Stevens, Fortson, Measham, & Sumnall, 2015). After the
implementation of Psychoactive Substances Act 2010 in
Ireland, 90% offline shops closed down (Kavanagh &
Power, 2014). A report by Smyth, James, Cullen, and
Darker (2015) showed that after the ban in Ireland, the
use of NPS was reduced but not eliminated and a report
from the Health Research Board (2015) found that deaths
from NPS increased.
Since the Psychoactive Substances Act in the UK is set to
criminalise online shops, and thus remove a primary supply
route of legal NPS, this paper explores: i. the hypothesis that
all online shops with a UK domain location will abide by the
new law; ii. the changes that arose to online shops preceding
the implementation of the ban; iii. the implications of the
findings on the NPS market after the introduction of the ban.
Methods
The search for online shops selling NPS were made throughout
October 2015. Search engine’s Google and Bingwere used
and various keywords were chosen to extract websites such as
‘‘buy’’ followed by ‘‘legal highs’’ or ‘‘research chemicals’’ or
‘‘bath salts’’ or ‘‘party pills’’ or ‘‘herbal highs’’.
For every keyword, the first five pages of results were
used, and those in the English language and distributed to the
UK were extracted. Data collected from the websites
included: last update of website; the country of domain; and
countries of distribution.
From the end of March until the beginning of June (2016),
data were collected on whether the online shops remained
open and whether they mentioned the ban, the delay of the
ban, or their closure. In the three days preceding the ban, data
were collected daily.
Data were collected using an Excel spreadsheet and a
descriptive analysis was conducted using SPSS version 21.
The research was observational and did not involve
interaction with either customers or shop owners. The study
was approved by King’s College London PNM Research
Ethics reference number: LRS-15/16-3084, as part of the
wider CASSANDRA project.
Results
In October 2015, a total of 113 shops selling NPS on the
Internet were found in the English language and shipped to
the UK. Substances were sold in different forms, some were
powders, herbal incense or pellets, and some were in branded
packages. The domain locations of the websites were recorded
before and after the ban on the 26th of May (Figure 1). Before
the ban, the domain locations of websites were predominantly
based in Europe (46%) and four fifths of those were in the
UK. After the ban, domain locations remained predominantly
in Europe (41%) closely followed by North America (37%);
however, the UK suffered the greatest reduction of shops,
losing a total of 31.
From the original 113 online shops that were collected in
October, 11 shops had already closed by April, and only 52%
remained open in May. Of those that remained open, the
majority (64%) were based overseas and shipped worldwide,
not just to the UK. Focussing on the UK, 14 shops had a UK
domain location prior to the ban, however, four shops
switched to a European server; three in Germany and one in
Norway. Ten UK-registered websites remained open (24% of
the original UK shops); nine removed the sale of NPS and
were headshops or cannabis seed stores and one was
Figure 1. The domain locations of the online
shops before and after the ban.
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presumed inactive. On the 26th of May, there were no
remaining active shops with a UK domain that were selling
NPS.
In the days preceding the date of implementation, the
number of open shops decreased from 98 to 65 (Table 1),
and fell to 59 shops in the days after the implementation.
Three days before the ban, 31% of shops communicated
updates of the legislation (Table 1), this dropped in the days
up to the 26th of May. On the day of the ban, 9% of shops that
were still open had updated or mentioned the day of the ban to
their customers. Few non-UK registered websites commu-
nicated with their customers about the pending ban. However,
some shops thanked their UK customers, and stated that they
would no longer be delivering to the UK.
The shops that updated their websites to notify their
customers of changes did so regularly. For example, Official
BenzoFury (officialbenzofury.net) frequently posted updates
to their website:
OBF [Official BenzoFury] are looking to purchase a
tropical island which will allow us to create our own laws
(1st April 2016).
UK Ban Has Been Delayed Further Details Will Be
Announced When Accuracy Of Reports Can Be
Confirmed (6th April 2016).
Possession is not an offence – stock up now (13th of May
2016).
We are now closed to our UK customers! (25th May 2016).
Discussion
From the original 113 online shops, all those with a domain
location in the UK that sold NPS closed down by the 26th
May of 2016, before their business became illegal. Ten (24%)
of the original UK-registered websites remained open but
removed sales of NPS to become a headshop and four (17%)
had moved domain locations and no longer sold NPS to UK
customers. This mirrors what was found by the UK
Government, that shops abide by the law and remove
substances once controlled (Home Office, 2014a). Of the 59
shops that remained open, they were either based overseas,
removed sales of NPS, or were no longer active. The
inactivity of the sites complements what was found by the
UK Home Office (2014b), where quality of sites differ greatly
and some update regularly and provide customer service,
whereas others do not update and merely display products. It
should be noted that 11 shops had already closed before data
collection in April had begun, suggesting early preparation or
a natural decay of a websites lifespan. Most of the shops that
closed in the preceding days before the ban had forewarned
their customers, either by updating their website with
information on the ban, promoting sales on stock or
promoting low stock that ‘‘must go’’. This suggests that the
stores may have closed rather than continued in underground
markets. However, it is suggested that sales of NPS would be
displaced to street level dealing or to the hidden web (Schmidt
et al., 2011; Stevens et al., 2015). The use of the hidden web
for the sale of drugs has increased in recent years (EMCDDA
& Europol, 2016), and thus an established platform is
arguably available to take the sales of the once legal UK NPS.
Limitations
Selection of online shops was only performed a single time
in October 2015; therefore the data does not include online
shops in the English language that opened after October.
The European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) performed a snapshot of NPS shops
online in Europe and found a higher number than in this
study (EMCDDA, 2014). However, our study’s inclusion
criteria focussed on the UK and only collected data from the
first five pages of search engines. This did not capture
online stores after the fifth page or not in the English
language. A total of 113 online shops were found to be
sufficient for studying the movement of retailers during the
changes of UK legislation. This study did not make any
purchases from the online shops, and so shop activity was
not confirmed. However, it was decided between the authors
that an up to date website and/or social media page was
sufficient evidence of activity.
Conclusions
For the online shops in this study, the stated motivation for
UK-registered websites to close or remove the sale of NPS
was the implementation of the Psychoactive Substances Act.
UK-registered websites abided by UK law, and closed down
or moved domain locations. The UK-registered websites
communicated with their customers about the initial ban, the
delay to the ban, and the implementation of the ban. Some
overseas shops notified customers that they would no longer
be distributing to the UK, however, the majority did not
mention the change of UK legislation. The majority of shops
in this study after the 26th of May were located elsewhere in
Europe or North America, showing that there is still high
demand for NPS in both of these continents (Smith & Garlich,
2013). From this brief study, it can be argued that the
Psychoactive Substances Act has achieved one of its aims in
the closure of online shops. However, further research is
required to understand where UK customers will obtain their
NPS, or whether they will return to traditional illicit drugs, or
perhaps cease taking NPS.
Table 1. The number of online shops open, and updates provided by the
shops in the days surrounding the implementation of the Psychoactive
Substances Act, 2016.
Dates in 2016
No. of
open shops
Updated
customers
(Ban, delay,
extension)
Early April 102 11
Original day of implementation (6th April) 101 16
End of April 98 21
Early May 101 24
3 days before implementation 98 30
2 days before implementation 88 29
1 day before implementation 76 16
Day of implementation (26th May) 65 6
1 day after implementation 64 5
Early June 59 4
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